IL17A and COVID-19: This association has been investigated by bioinformatic analyses examining potential genetic crosstalk between HZ and COVID-19, and increases in Th17 cell differentiation and, consequently, IL-17 signaling have been described in both COVID-19 and HZ, suggesting that IL-17 signaling may be one mechanism through which COVID-19 can increase the risk of HZ.17